|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-10-18
|
|
pubmed:abstractText |
Adrenomedullin, a potent endogenous vasodilating and natriuretic peptide, may play an important role in the pathophysiology of chronic heart failure. Plasma levels of immunoreactive adrenomedullin were examined for prediction of prognosis in chronic heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1009-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10901513-Adrenomedullin,
pubmed-meshheading:10901513-Adult,
pubmed-meshheading:10901513-Aged,
pubmed-meshheading:10901513-Cardiac Output, Low,
pubmed-meshheading:10901513-Chronic Disease,
pubmed-meshheading:10901513-Female,
pubmed-meshheading:10901513-Follow-Up Studies,
pubmed-meshheading:10901513-Humans,
pubmed-meshheading:10901513-Male,
pubmed-meshheading:10901513-Middle Aged,
pubmed-meshheading:10901513-Peptides,
pubmed-meshheading:10901513-Prognosis,
pubmed-meshheading:10901513-Radioimmunoassay
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.
|
|
pubmed:affiliation |
Department of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
